Evaluation of multiple breast cancer polygenic risk score panels in women of Latin American heritage.

IF 3.7 3区 医学 Q2 ONCOLOGY
Xiaosong Huang, Paul C Lott, Donglei Hu, Valentina A Zavala, Zoeb N Jamal, Tatiana Vidaurre, Sandro Casavilca-Zambrano, Jeannie Navarro Vásquez, Carlos A Castañeda, Guillermo Valencia, Zaida Morante, Mónica Calderón, Julio E Abugattas, Hugo A Fuentes, Ruddy Liendo-Picoaga, Jose M Cotrina, Silvia P Neciosup, Patricia Rioja Viera, Luis A Salinas, Marco Galvez-Nino, Scott Huntsman, Sixto E Sanchez, Michelle A Williams, Bizu Gelaye, Ana P Estrada-Florez, Guadalupe Polanco-Echeverry, Magdalena Echeverry, Alejandro Velez, Jenny A Carmona-Valencia, Mabel E Bohorquez-Lozano, Javier Torres, Miguel Cruz, Weang-Kee Ho, Soo Hwang Teo, Mei Chee Tai, Esther M John, Christopher A Haiman, David V Conti, Fei Chen, Gabriela Torres-Mejía, Lawrence H Kushi, Susan L Neuhausen, Elad Ziv, Luis G Carvajal-Carmona, Laura Fejerman
{"title":"Evaluation of multiple breast cancer polygenic risk score panels in women of Latin American heritage.","authors":"Xiaosong Huang, Paul C Lott, Donglei Hu, Valentina A Zavala, Zoeb N Jamal, Tatiana Vidaurre, Sandro Casavilca-Zambrano, Jeannie Navarro Vásquez, Carlos A Castañeda, Guillermo Valencia, Zaida Morante, Mónica Calderón, Julio E Abugattas, Hugo A Fuentes, Ruddy Liendo-Picoaga, Jose M Cotrina, Silvia P Neciosup, Patricia Rioja Viera, Luis A Salinas, Marco Galvez-Nino, Scott Huntsman, Sixto E Sanchez, Michelle A Williams, Bizu Gelaye, Ana P Estrada-Florez, Guadalupe Polanco-Echeverry, Magdalena Echeverry, Alejandro Velez, Jenny A Carmona-Valencia, Mabel E Bohorquez-Lozano, Javier Torres, Miguel Cruz, Weang-Kee Ho, Soo Hwang Teo, Mei Chee Tai, Esther M John, Christopher A Haiman, David V Conti, Fei Chen, Gabriela Torres-Mejía, Lawrence H Kushi, Susan L Neuhausen, Elad Ziv, Luis G Carvajal-Carmona, Laura Fejerman","doi":"10.1158/1055-9965.EPI-24-1247","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A substantial portion of the genetic predisposition for breast cancer is explained by multiple common genetic variants of relatively small effect. A subset of these variants, which have been identified mostly in individuals of European and Asian ancestry, have been combined to construct a polygenic risk score (PRS) to predict breast cancer risk, but the prediction accuracy of existing PRSs in Hispanic/Latinx individuals (H/L) remain relatively low. We assessed the performance of several existing PRS panels with and without addition of H/L specific variants among self-reported H/L women.</p><p><strong>Methods: </strong>PRS performance was evaluated using multivariable logistic regression and the area under the receiver operating characteristic curve (AUC).</p><p><strong>Results: </strong>Both European and Asian PRSs performed worse in H/L samples compared to original reports. The best European PRS performed better than the best Asian PRS in pooled H/L samples. European PRSs had decreased performance with increasing Indigenous American (IA) ancestry while Asian PRSs had increased performance with increasing IA ancestry. The addition of 2 H/L SNPs increased performance for all PRSs, most notably in the samples with high IA ancestry and did not impact the performance of PRSs in individuals with lower IA ancestry.</p><p><strong>Conclusions: </strong>A single PRS that incorporates risk variants relevant to the multiple ancestral components of individuals from Latin America, instead of a set of ancestry specific panels, could be used in clinical practice.</p><p><strong>Impact: </strong>Results highlight the importance of population-specific discovery and suggest a straightforward approach to integrate ancestry specific variants into PRS for clinical application.</p>","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology Biomarkers & Prevention","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/1055-9965.EPI-24-1247","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A substantial portion of the genetic predisposition for breast cancer is explained by multiple common genetic variants of relatively small effect. A subset of these variants, which have been identified mostly in individuals of European and Asian ancestry, have been combined to construct a polygenic risk score (PRS) to predict breast cancer risk, but the prediction accuracy of existing PRSs in Hispanic/Latinx individuals (H/L) remain relatively low. We assessed the performance of several existing PRS panels with and without addition of H/L specific variants among self-reported H/L women.

Methods: PRS performance was evaluated using multivariable logistic regression and the area under the receiver operating characteristic curve (AUC).

Results: Both European and Asian PRSs performed worse in H/L samples compared to original reports. The best European PRS performed better than the best Asian PRS in pooled H/L samples. European PRSs had decreased performance with increasing Indigenous American (IA) ancestry while Asian PRSs had increased performance with increasing IA ancestry. The addition of 2 H/L SNPs increased performance for all PRSs, most notably in the samples with high IA ancestry and did not impact the performance of PRSs in individuals with lower IA ancestry.

Conclusions: A single PRS that incorporates risk variants relevant to the multiple ancestral components of individuals from Latin America, instead of a set of ancestry specific panels, could be used in clinical practice.

Impact: Results highlight the importance of population-specific discovery and suggest a straightforward approach to integrate ancestry specific variants into PRS for clinical application.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Epidemiology Biomarkers & Prevention
Cancer Epidemiology Biomarkers & Prevention 医学-公共卫生、环境卫生与职业卫生
CiteScore
6.50
自引率
2.60%
发文量
538
审稿时长
1.6 months
期刊介绍: Cancer Epidemiology, Biomarkers & Prevention publishes original peer-reviewed, population-based research on cancer etiology, prevention, surveillance, and survivorship. The following topics are of special interest: descriptive, analytical, and molecular epidemiology; biomarkers including assay development, validation, and application; chemoprevention and other types of prevention research in the context of descriptive and observational studies; the role of behavioral factors in cancer etiology and prevention; survivorship studies; risk factors; implementation science and cancer care delivery; and the science of cancer health disparities. Besides welcoming manuscripts that address individual subjects in any of the relevant disciplines, CEBP editors encourage the submission of manuscripts with a transdisciplinary approach.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信